Net sales | 2.11B |
Cost of products sold | 594M |
Gross profit | 1.51B |
Operating expenses: | |
Selling, general and administrative expenses | 772M |
Research and development expenses | 232M |
Royalty expense | 20M |
Amortization expense | 136M |
Goodwill impairment charge | |
Intangible asset impairment charges | 7M |
Contingent consideration expense | |
Acquisition-related milestone | |
Restructuring charges | 5M |
Gain on divestiture | |
Operating expenses | 1.16B |
Operating income (loss) | 348M |
Other income (expense): | |
Interest expense | -58M |
Other, net | -33M |
Income (loss) before income taxes | 257M |
Income tax expense | 29M |
Net income (loss) | 228M |
Net income (loss) per common share - basic | 0.17 |
Net income (loss) per common share - assuming dilution | 0.17 |
Weighted-average shares outstanding | |
Basic | 1.36B |
Assuming dilution | 1.38B |